TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMA

ImageneBio, Inc.

Healthcare · Biotechnology

4.80$ -1.6% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

ImageneBio, Inc. (IMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 152 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
215 192 173 157 149 142 131 126 161 153 137 152
201 179 161 149 142 127 117 99 148 140 122 141
121 120 53 44 45 39 37 58 103 35 76 95
197 175 157 145 138 124 114 96 143 76 117 136
0.7 1.3 2.6
28 22 17 15 15 16 13 10 21 20 13 10.0
19 14 10 8.2 9.2 11 8.8 7.3 11 11 6.6 6.6
3.5 3.6 3.4 3.7 3.9 3.8 3.9 3.8 2.2 2.3 2.3 1.9
4.0 2.1 1.9 1.4 1.5 0.9 0.8 0.5 2.1 1.4 0.6 1.0
187 170 155 143 134 126 118 116 140 133 123 142
-263 -282 -299 -312 -322 -332 -340 -343 -223 -230 -241 -251
3.6 4.0 4.0 4.0 1.4 1.4 1.4 2.4 8.5 11 11 16

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?